Retrospective Analysis of Real-World Treatment Patterns and Survival Outcomes for Non-small Cell Lung Cancer Patients in Thailand

被引：0
|
作者：
Supaattagorn, S. [1 ]
Maneenil, K. [1 ,2 ]
机构：
[1] Rajavithi Hosp, Dept Med, Oncol unit, Bangkok, Thailand
[2] Rangsit Univ, Coll Med, Bangkok, Thailand
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Real-world outcomes; NSCLC; treatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP10.01-05
引用
收藏
页码：S603 / S604
页数：2
相关论文
共 50 条
  • [31] The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer
    Chen, Hanxiao
    Huang, Dingzhi
    Lin, Gen
    Yang, Xue
    Zhuo, Minglei
    Chi, Yujia
    Zhai, Xiaoyu
    Jia, Bo
    Wang, Jingjing
    Wang, Yuyan
    Li, Jianjie
    An, Tongtong
    Wu, Meina
    Wang, Ziping
    Zhao, Jun
    CANCER MEDICINE, 2022, 11 (19): : 3581 - 3592
  • [32] RETROSPECTIVE ANALYSIS OF PEMETREXED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kitazaki, Takeshi
    Ogawara, Daiki
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Shimada, Midori
    Ikeda, Takaya
    Tomonaga, Nanae
    Soda, Hiroshi
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S489 - S489
  • [33] Incidence and Risk Factors of Pneumonitis in Patients with Non-Small Cell Lung Cancer: An Observational Analysis of Real-World Data
    Tyczynski, Jerzy E.
    Potluri, Ravi
    Kilpatrick, Ryan
    Mazumder, Debasish
    Ghosh, Anirban
    Liede, Alexander
    ONCOLOGY AND THERAPY, 2021, 9 (02) : 471 - 488
  • [34] Incidence and Risk Factors of Pneumonitis in Patients with Non-Small Cell Lung Cancer: An Observational Analysis of Real-World Data
    Jerzy E. Tyczynski
    Ravi Potluri
    Ryan Kilpatrick
    Debasish Mazumder
    Anirban Ghosh
    Alexander Liede
    Oncology and Therapy, 2021, 9 : 471 - 488
  • [35] Metronomic oral vinorelbine in a real-world population of advanced non-small cell lung cancer patients
    Estevinho, Fernanda
    Gomes, Rita
    Hasmucrai, Direndra
    Barata, Fernando
    PULMONOLOGY, 2022, 28 (05): : 368 - 375
  • [36] Durvalumab real-world treatment patterns and outcomes in patients with stage III non-small-cell lung cancer treated in a US community setting
    Waterhouse, David
    Yong, Candice
    Frankart, Andrew
    Brannman, Lance
    Mulrooney, Tiernan
    Robert, Nicholas
    Aguilar, Kathleen M.
    Ndukum, Juliet
    Cotarla, Ion
    FUTURE ONCOLOGY, 2023, 19 (28) : 1905 - 1916
  • [37] Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis
    Ay, Leyla
    Steiner, Daniel
    Fabikan, Hannah
    Illini, Oliver
    Krenbek, Dagmar
    Klikovits, Thomas
    Benej, Michal
    Kirchbacher, Klaus
    Watzka, Stefan
    Valipour, Arschang
    Hochmair, Maximilian
    LUNG CANCER, 2024, 198
  • [38] Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients
    Britschgi, Christian
    Addeo, Alfredo
    Rechsteiner, Markus
    Delaloye, Raphael
    Frueh, Martin
    Metro, Giulio
    Banini, Marco
    Gautschi, Oliver
    Rothschild, Sacha I.
    Wild, Peter J.
    Banna, Giuseppe L.
    Curioni-Fontecedro, Alessandra
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Jinghua He
    Christopher D. Pericone
    Julie Vanderpoel
    Advances in Therapy, 2022, 39 : 3347 - 3360
  • [40] Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    He, Jinghua
    Pericone, Christopher D.
    Vanderpoel, Julie
    ADVANCES IN THERAPY, 2022, 39 (07) : 3347 - 3360
12345